Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stock

Showing results (211-220 of 322) with videos related to

Pageof 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemiaRebecca B Klisovic, Wendy Stock, Spero Cataland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on AgeColin Flannelly, Bryan E-Xin Tan, Jian Liang Tan, et al.
Blood|October 7, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemiaMarlise R Luskin, Mark A Murakami, Julia Keating, et al.
Blood Neoplasia|August 12, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United StatesBrandon DaSilva, Alicia Darwin, Amy Zhang, et al.
Blood Advances|October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.
The Lancet. Oncology|February 19, 2020
Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor StudyEugene Suh, Kayla L Stratton, Wendy M Leisenring, et al.
Haematologica|April 15, 2024
Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantationGregory W Roloff, Satyajit Kosuri, Mariam T Nawas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic LeukemiaSatoshi Yoshimura, Yizhen Li, Shutaro Inoue, et al.
Blood Advances|December 1, 2023
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adultsHannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, et al.
Blood Advances|August 21, 2023
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology studyBhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, et al.
Pageof 33

Showing results (211-220 of 322) with videos related to

Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemiaRebecca B Klisovic, Wendy Stock, Spero Cataland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on AgeColin Flannelly, Bryan E-Xin Tan, Jian Liang Tan, et al.
Blood|October 7, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemiaMarlise R Luskin, Mark A Murakami, Julia Keating, et al.
Blood Neoplasia|August 12, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United StatesBrandon DaSilva, Alicia Darwin, Amy Zhang, et al.
Blood Advances|October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.
The Lancet. Oncology|February 19, 2020
Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor StudyEugene Suh, Kayla L Stratton, Wendy M Leisenring, et al.
Haematologica|April 15, 2024
Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantationGregory W Roloff, Satyajit Kosuri, Mariam T Nawas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic LeukemiaSatoshi Yoshimura, Yizhen Li, Shutaro Inoue, et al.
Blood Advances|December 1, 2023
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adultsHannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, et al.
Blood Advances|August 21, 2023
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology studyBhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, et al.
Pageof 33